Chronic News and Research

RSS

New Australian centre for obesity, nutrition, exercise and public health

The Institute of Obesity, Nutrition & Exercise will draw together some of Australia's leading researchers, scientists and academics in four key divisions; Obesity, Nutrition, Exercise, and Public Health, Epidemiology and Policy.

27 Jul 2007

Europe approves MIRCERA to treat anaemia

Roche has announced that the European Commission has approved its innovative drug MIRCERA to treat anaemia associated with chronic kidney disease (CKD).

27 Jul 2007

Women more prone to brain damage from alcohol abuse than men

Alcoholism has traditionally been considered a male disease because there are many more alcoholic males than females.

27 Jul 2007

Medtronic receives FDA approval for first artificial disc for the neck

Millennium Research Group (MRG) has conducted a detailed analysis of the US spinal implant market in its US Markets for Spinal Implants report.

26 Jul 2007

Combination of blood pressure-lowering drugs stops loss of kidney function in rare genetic disease

A combination of two types of blood pressure-lowering drugs, an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) with agalsidase-beta (Fabrazyme, Genzyme Corporation, Cambridge, MA) is the first treatment shown to stop progressive loss of kidney function in patients with severe kidney involvement due to the rare genetic disorder Fabry disease, reports a study in the September Journal of the American Society of Nephrology.

26 Jul 2007

ZARS starts phase 3 trial of ThermoProfen

ZARS, Inc., has announced that it commenced the first of two Phase 3 clinical trials of ThermoProfen in patients with mild to moderate osteoarthritis (OA) of the knee on June 26, 2007.

26 Jul 2007

Itchy and scratchy gene discovered

Itching for a better anti-itch remedy? Your wish may soon be granted now that scientists at Washington University School of Medicine in St. Louis have identified the first gene for the itch sensation in the central nervous system.

26 Jul 2007

Metformin gets top grade for diabetes

A type 2 diabetes drug taken orally and in widespread use for more than a decade has been found to have distinct advantages over nine other, mostly newer medications used to control the chronic disease, according to a study by researchers at Johns Hopkins.

26 Jul 2007

Prenatal alcohol exposure alters brain activity in the frontal-striatal areas

Heavy prenatal alcohol exposure does not always lead to fetal alcohol syndrome (FAS); sometimes it can lead to cognitive and behavioral deficits in the absence of craniofacial features needed to make an FAS diagnosis.

25 Jul 2007

Diabetes epidemic in New York City

The diabetes epidemic is taking a large and growing toll on New York City, a new Health Department report shows, as death rates, debilitating complications, and hospitalization costs soar.

25 Jul 2007

Alkaline diet can combat the effects of acid reflux

Gastroesophageal Reflux Disease (GERD), more commonly known as acid reflux, affects 19.8 percent of adults in the United States (roughly 47.3 million people).

25 Jul 2007

Low literacy can shorten life

Not being able to read doesn't just make it harder to navigate each day. Low literacy impairs people's ability to obtain critical information about their health and can dramatically shorten their lives.

24 Jul 2007

Being elderly and illiterate means a significantly higher mortality rate

Researchers in the U.S. have found that being elderly and being unable to read and understand basic health information is a bad combination.

24 Jul 2007

Double depression

There's depression, and then there's double depression.

24 Jul 2007

Study looks at cancer incidence among recipients of blood from donors

Individuals who receive blood transfusions from donors with undiagnosed cancers are at no higher risk of developing malignant disease than people who receive blood from donors without cancer, according to the results of a retrospective study published in The Lancet last month.

23 Jul 2007